Cerebras looks attractive because the short report's two-year wafer-life thesis rests on unvalidated reliability assumptions, not representative failure data. Energy per useful token, lower warranty utilization and ordinary repair accounting also undercut its financial conclusions. OpenAI has integrated Cerebras into production; AMD and AWS have announced integrations, while Oracle plans 2027 availability for ultra-fast inference, adding commercial validation despite the report. x.com  x.com 

Cerebras is a speculative, high-risk, high-reward bet on faster inference that could make its $44B market cap a multi-bagger if it works. Putting the whole processor and memory on one wafer wins on speed, not cheaper memory, since on-chip SRAM costs more per bit than HBM; Nvidia is answering via Groq. G42 and MBZUAI were 86% of 2025 revenue, but the ramp ahead is tied to OpenAI. The $160s level has held as support four times since the IPO. Size it to one's capital-preservation goals. x.com 

Cerebras's share price already assumes years of flawless execution, so investors can be right about the company long term and still lose money. Two customers make up 86% of revenue, it posted a $146 million operating loss in 2025, its GAAP profit came from accounting gains, and it trades at 111x revenue. The wafer-scale technology, 15x faster AI inference and $20B+ OpenAI compute deal make the bull case real, but the price leaves no margin for early-stage setbacks. x.com 

Cerebras' inference opportunity can support substantial long-term upside if installed capacity grows from 60MW to 3.2GW by 2031 and OpenAI renews after 2028. The risk-adjusted model puts 2031 value at $485-$700 per share while assuming rivals narrow its speed premium and customers and partners fund most capex. If those assumptions fail, capex, dilution and valuation risk rise. x.com 

Cerebras has significant multi-year upside because its wafer-scale chip does fast inference better than anything else, and latency-sensitive inference is growing about 2x faster than training. Holding the whole model in on-chip SRAM gives up to 15x faster inference than leading GPU solutions; it took OpenAI's fast-inference business from NVIDIA, and management has already raised prices on excess demand. A $20B take-or-pay OpenAI deal for 750MW through 2028 anchors $24.6B of RPO. x.com  x.com 

Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras's post-earnings selloff reflects an inability to deliver fast enough yet, not weak demand, a setup like an early Nebius. Its hardware IP delivers the most efficient inference on the market and already draws massive demand from Amazon and OpenAI, on the conviction that inference becomes AI's main demand source and speed the differentiator. What it lacks is infrastructure to scale hardware production and cloud capacity. The open question is whether it can execute as Nebius did. x.com 

Cerebras keeps memory on the wafer, which suits agents making many latency-sensitive model calls; it might be the most interesting AI hardware stock to buy now and revisit in three years. UBS estimates revenue rising from $890M in 2026 to $22.6B by 2030 and operating margin from -18% to 46%. At $146, shares trade at about 20x UBS's 2028 earnings and 10x 2029. Execution is everything, but even halfway to those projections, $146 may not look expensive for long. x.com 

Cerebras at over 100x sales with execution hurdles is not a low-risk buy, so it is better to sit out for now. It is a pure AI hardware bet: if wafer-scale chips take meaningful share from NVIDIA and revenue grows 2-4x or more in two years, the roughly $237 price could look reasonable long term. It suits only aggressive growth investors who can stomach 30-50% swings. x.com 

Vicor's efficient delivery of key power modules is part of the case for Cerebras meeting and exceeding its 2028-29 numbers. As models improve, more security breaches and deployments should make Cerebras look increasingly like a cybersecurity play. Its revenue ramp looks constrained by capacity, not yet by demand. Bullish on Cerebras but cautious on the broader market, with no short-term earnings prediction. x.com  x.com  x.com  x.com